| Alias
|
Vasocyclin
|
|
PGI(2)
|
|
6,9-alpha-Epoxy-11-alpha,15(S)-dihydroxyprosta-5(Z),13(E)-dien-1-oic acid
|
|
6,9-alpha-Epoxy-11-alpha,15(S)-dihydroxyprosta-5(Z),13(E)-dien-1-oate
|
|
[14C]prostacyclin
|
|
prostacycline
|
|
Epoprostenol Sodium
|
|
U 53,217A
|
|
U 53,217
|
|
Sodium (5Z,13E,15S)-6,9alpha-epoxy-11alpha,15-dihydroxyprosta-5,13-dien-1-oate
|
|
Sodium (Z)-(3aR,4R,5R,6aS)-hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valerate
|
|
Flolan
|
|
epoprostenol sodium salt
|
|
[3H]prostacyclin
|
|
Epoprostenol
|
|
Epoprostenolum
|
|
Epoprostanol
|
|
EINECS 263-273-7
|
|
Cyclo-Prostin
|
|
BRN 1690090
|
|
Epoprosterol sodium
|
|
prostaglandine I2
|
|
Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer
|
|
PGI(1)
|
|
[11-3H]prostacyclin
|
|
(5z,13e)-(15s)-6,9-alpha-epoxy-11-alpha,15-dihydroxyprosta-5,13-dienoate
|
|
(5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxy-Prosta-5,13-dien-1-oate
|
|
(5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxy-Prosta-5,13-dien-1-oic acid
|
|
(5Z,9alpha,11alpha,13E,15S)-6,9-epoxy-11,15-dihydroxy-Prosta-5,13-dien-1-oic acid sodium salt
|
|
(Z)-(3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valerate
|
|
(Z)-(3aR,4R,5R,6aS)-Hexahydro-5-hydroxy-4-((E)-(3S)-3-hydroxy-1-octenyl)-2H-cyclopenta(b)furan-delta(sup 2,delta)-valeric acid
|
|
PGI2
|
|
PG011
|
|
prostaglandine (PG) I2
|
|
PGI1
|
|
Prostacyclin
|
|
Prostacyclin sodium salt
|
|
prostacyclin-14C
|
|
prostacyclin-3H
|
|
KB-IV-24
|
|
Prostacyclins
|
|
prostaglandin 12
|
|
prostaglandin I2
|
|
prostaglandin X
|
|
prostaglandin [PG] I2
|